The Chemistry and Biology of Bioflavonoids
Amit Tapas1*, Dinesh Sakarkar1, Rajendra Kakde2
1Sudhakarrao Naik Institute of Pharmacy, Pusad- 445204, Dist.-Yavatmal (MS) India
2University Department of Pharmaceutical Sciences, R.T.M. Nagpur University, Nagpur-440033 (MS) India
* Corresponding Author E-mail: amit.tapas@gmail.com
ABSTRACT
Phenolic compounds form one of the main class of secondary metabolites. They display a large range of structures and
are responsible for the major organoleptic characteristics of plant-derived-foods and beverages, particularly color and taste properties and they also contribute to the nutritional qualities of fruits and vegetables. Among these compounds flavonoids constitute one of the most ubiquitous groups of all plant phenolics. Owing to their importance in food organoleptic properties and in human health, a better understanding of their structure, biosynthesis, chemical synthetic methodologies and various biological activities appears essential to make them as potential therapeutic agents and also to predict and control food quality. The purpose of this work is an overview of structural diversities, synthetic methodologies and shed a light on biological activities. The first part of this review concerns the structural aspects, biosynthetic and synthetic schemes for different classes of flavonoids. Regarding the synthesis of flavonoids various schemes have been highlighted to obtain variety of higher potent flavonoid derivatives. These schemes can be applicable at regular laboratory levels. The second part of this review concerns the various biological properties of flavonoids on plant as well as on mammalian cells. Recently this group of natural products has gained much interest as bioactive compounds. Because of the variety of pharmacological activities on mammalian body flavonoids are more correctly referred as “Nutraceutical”.
KEY WORDS Bioflavonoids; Chemistry; Biological Activities; Review.
INTRODUCTION:
Phenolic compounds form one of the main class of
secondary metabolites. They display a large range of structures and are responsible for the major organoleptic characteristics of plant-derived-foods and beverages, particularly color and taste properties and they also contribute to the nutritional qualities of fruits and vegetables. Among these compounds flavonoids constitute one of the most ubiquitous groups of all plant phenolics. The most important natural pigments are carotenoids, tetrapyrrole derivatives of naturally occurring phenolic compounds ubiquitously distributed in plant kingdom. So far over 8,000 varieties of flavonoids have been identified1. Until ~50 years ago, information on the working mechanisms of flavonoids was scare. But it has been widely known for centuries that compounds of plant origin possesses broad spectrum of biological activity2. In 1930, Szent- Gyorgyi isolated a new substance from oranges and classifies it as a vitamin, Vitamin P. But latter it came clear that this substance was a flavonoid. Flavonoids have created a more attention of researcher with the discovery of the French Paradox, i.e. decrease incidence of cadio-vascular disease observed in Mediterranean population, in association with red wine consumption and a greater amount of saturated fat than average diet in other countries3. In this review it is attempted to describe current knowledge on structural aspects, biosynthetic and synthetic routes of flavonoids.
STRUCTURE AND CLASSIFICATION OF FLAVONOIDS:
Flavonoids occur as aglycones, glycosides and methylated derivatives4. In plants, flavonoids aglycones (i.e. flavonoids without attached sugar) occur in a variety in a variety of structural forms. All contain fifteen carbon atoms in their
basic nucleus: two six membered rings linked with a three carbon unit which may or may not be a part of third ring5. For convenience the rings are labeled A, B, and C. The individual carbon atoms are based on a numbering system, which uses ordinary numeral for the A and C and “primed” numerical for B-ring (1). Primed modified numbering system is not used for chalcones (2) and the isoflavones derivatives (6): the pterocarpans and the rotenoids6. The different ways to close this ring associated with the different oxidation degrees of ring A provide the various classes of flavonoids. linkage is normally located at position 3 or 7 and carbohydrate unit can be L-rhamnose, D-glucose, glucorhamnose, galactose or arabinose9. and “Acetate Malonate” pathways, the first flavonoid initially formed in the biosynthesis is the chalcone and all other forms are derived from this variety of routes10. Further
Figure 1. Chemical structure of some representative flavonoids
The six member ring condensed with the benzene ring is either a γ-pyrone (flavones (1) flavonols (3)) or its dihydroderivative (flavanones (4) and flavan-3-ols (5)). The position of benzenoid substituent divides the flavonoids into two classes as flavonoids (1) (2- position) and isoflavonoids (6) (3-position). Biflavonoid (9), (10) is dimmer having similar
(biflavone, biflavanone) or dissimilar (flavanone-
modification of flavonoid may occur at various stages
resulting in additional (or reduced) hydroxylation, methylation of hydroxyl groups or of flavonoid nucleus, isoprenylation of hydroxyl groups or of the flavonoid nucleus, methylenation of ortho-dihyroxyl groups, dimerisation (to produce biflavonoids), bisulphate formation, and most importantly, glycosylation of hydroxyl groups (to produce flavonoid o-glycosides) or of flavonoid nucleus (to produce flavonoid C-glycosides)11-12.
Flavonoids are synthesized via the phenylpropanoid
13
flavone, flavone-isoflavone, flavanone-chalcone)
pathway
. Phenylalanine ammonia lyase (PAL) catalyzes
14, 15
flavonoid moieties in their structure. These monomer
the conversion of phenylalanine to cinnamate
. PAL also
units usually bound to one another through C-6 or C-
shows activity with converting tyrosine to p-coumarate,
16
87. In prenylated flavonoids (11), (12)
albeit to a lower efficiency
. The cinnamate 4-hydroxylase
prenyl/isopentenyl or their furano/dimethyl chromano
(C4H) catalyzes the synthesis of p-hydroxycinnamate from
17
derivatives, as well as the geranyl and farnesyl side
cinnamate and 4-coumarate
:CoA ligase (4CL) converts p-
attachment is present. Generally, the most flavonoids are C-prenylated and more frequently on ring ‘A’ at position 6/8 as well as on position 3’/5’ especially in flavanones and flavones8. Most flavonoids occurs naturally associated with sugar in conjugated form and within any one class may be characterized as monoglycosidic, diglycosidic, etc. the glycosidic
coumarate to its coenzyme-A ester, activating it for reaction
with malonyl CoA18.
The flavonoid biosynthetic pathway starts with the condensation of one molecule of 4-coumaroyl-CoA and three molecules of malonyl-CoA, yielding naringenin chalcone19. This reaction is carried out by the enzyme
Figure 3. Examples showing structures of some prenylated flavonoids. General Structure
|
Group |
3 |
5 |
6 |
7 |
8 |
3’ |
4’ |
5’ |
C2=C3 |
|
Flavones |
|
||||||||
|
Apigenin |
H |
OH |
H |
OH |
H |
H |
OH |
H |
+ |
|
Diosmin |
H |
OH |
H |
Oru |
H |
OH |
OH |
H |
+ |
|
Luteolin |
H |
OH |
H |
OH |
H |
OH |
OH |
H |
+ |
|
Flavonol |
|
||||||||
|
Quercetin |
OH |
OH |
H |
OH |
H |
OH |
OH |
H |
+ |
|
Kaempferol |
OH |
OH |
H |
OH |
H |
H |
OH |
H |
+ |
|
Galangin |
OH |
OH |
H |
OH |
H |
H |
H |
H |
+ |
|
Fisetin |
OH |
H |
H |
OH |
H |
OH |
OH |
H |
+ |
|
Myricetin |
OH |
OH |
H |
OH |
H |
OH |
OH |
OH |
+ |
|
Vitexicarpin |
OCH3 |
OH |
OCH |
OCH3 |
H |
OH |
OCH3 |
H |
+ |
|
Flavanone |
|
||||||||
|
Naringenin |
H |
OH |
H |
OH |
H |
H |
OH |
H |
- |
|
Eriodictyol |
H |
OH |
OH |
OH |
H |
OH |
OH |
H |
- |
|
Pinocembrin |
H |
OH |
H |
OH |
H |
H |
H |
H |
- |
|
Liquiritigenin |
H |
H |
H |
OH |
H |
H |
OH |
H |
- |
|
Flavanonol |
|
||||||||
|
Taxifolin |
H |
OH |
H |
OH |
H |
OH |
OH |
H |
- |
|
Isoflavone |
|
||||||||
|
Genistein |
- |
OH |
H |
OH |
H |
H |
OH |
H |
+ |
|
Tectorigenin |
- |
OH |
OCH3 |
OH |
H |
H |
OH |
H |
+ |
|
Daidzein |
- |
H |
H |
OH |
H |
H |
OH |
H |
+ |
|
Formononetin |
- |
H |
H |
OH |
H |
H |
OCH3 |
H |
+ |
|
Flavan-3-ols |
|
||||||||
|
(+) Catechin |
βOH |
OH |
H |
OH |
H |
OH |
OH |
H |
- |
|
(-) Epicatechin |
αOH |
OH |
H |
OH |
H |
OH |
OH |
H |
- |
|
(-) Epigallocatechin |
αOH |
OH |
H |
OH |
H |
OH |
OH |
OH |
- |
|
Flavylium Salts |
|
||||||||
|
Cyanidin |
OH |
OH |
H |
OH |
H |
OH |
OH |
H |
- |
|
Pelargonidine |
OH |
OH |
H |
OH |
H |
H |
OH |
H |
- |
chalcone synthase (CHS)19. Chalcone is isomerised to a flavanone by the enzyme chalcone flavanone isomerase (CHI)20. From these central intermediates, the pathway diverges into several side branches, each resulting in a different class of flavonoids. Flavanone 3-hydroxylase (F3H) catalyzes the stereospecific 3β-hydroxylation of (2S)-flavanones to dihydroflavonols21-24. For the biosynthesis of anthocyanins, dihydroflavonol reductase (DFR) catalyzes the reduction of dihydroflavonols to flavan-3,4-diols (leucoanthocyanins)25, which are converted to anthocyanidins by anthocyanidin synthase (ANS)26-28. The formation of glucosides is catalyzed by UDP glucose-flavonoid 3-o-glucosyl transferase (UFGT), which stabilize the anthocyanidins by 3-O- glucosylation (Harborne 1994, Bohm 1998)29. The overview of the flavonoid pathway is presented in Figure 5. There is evidence that the enzymes involved in flavonoid metabolism might be acting as membrane- associated multienzyme complexes, which has implications on the overall efficiency, specificity, and regulation of the pathway (Stafford 1991, Winkel-Shirley 1999, 2001)30.
Figure 4. Interrelationship between flavonoids for biosynthetic pathways.
CHEMICAL SYNTHETIC ROUTES FOR FLAVONOIDS
Flavonoids have been a topic of research for more than
one century. Some scientist have been trying to get their extracts from different plants and different parts of plants, and some started a course of synthetic experiments to afford the flavonoids. The isolation of bioflavonoids is carried out via an extraction process, but usually the plants contain a variety of derivatives in low concentration. Thus a large amount of dried raw material and laborious chromatographic purification schemes are needed to isolate quantities of individual compounds. So synthetic routes may be useful to get selective flavonoid compounds. In this review, we have tried to focus various synthetic schemes available for flavonoids synthesis. Various methods have been reported regarding the synthesis of flavonoids. The interest in these methods is that these syntheses allow the establishment with certainty the structure of naturally occurring flavonoids by preparing them unequivocally from known starting materials. It was also enabled the workers to elucidate biosynthetic
31-33
heterocycle ring directly while in other cases some interconversion is necessary. Four classical flavonoid synthetic routes are reported to be used namely Claisen- Schmidt, Baker-Venkataraman, Allan-Robinson and Algar- Flynn-Oyamada methods.
The most important intermediates to obtain
Chalcones
2’-hydroxy chalcones (15) are the most important
intermediates for the synthesis of flavonoids like flavones, flavonols, 3-hydroxyflavanones and aurones. The formation of chalcone was reported to involve the Claisen-Schmidt condensation of aromatic aldehyde (14) with acetophenone (13) in the presence of alkali as a catalyst. (Figure 6) flavonoids can be prepared to study their usefulness as flavoring/coloring additive or as potential drugs.
Two major pathways
The synthesis of flavones was first reported around
1900. The methods those have synthetic importance are divided into two chemical routes (Figure 6).
1. Substitution of phenol with an α,β-unsaturated acyl chloride.
2. Substitution of an acetophenone with a benzaldehyde, a benzoyl anhydride, or benzoyl
chloride.
Table 2: Reactive oxygen species that can be scavenged or whose formation can be inhibited by flavonoids69-70.
|
O3(Superoxide anion) |
One-electron reduction product of O2. Produced by phagocytes, formed in autoxidation reactions (flavoproteins, redox cyclin._g), and generated by oxidases (heme proteins). |
|
HO2 |
Potonated form of O2. |
|
H2O2 (Hydrogen Peroxide) |
Two-electron reduction product of O2 formed from O2 by dismutation or directly from O2. Reactivity of O and H O is amplified in the presence._of heme proteins. ._ ._ 2 2 2 |
|
OH (Hydroxy radical) |
Three-electrons reduction product of O2 generated by Fenton reaction, transition metal (iron, copper)- catalysed Haber-Weiss reaction; also formed by decomposition of peroxynitrite produced by the reaction of O2 with NO. (Nitric oxide radical). |
|
RO. (Alkoxy radical) |
Example: Lipid radical (LO.). ._ |
|
ROO. (Peroxyl radical) |
Example: Lipid peroxy radical (LOO.) produced from organic hydroperoxide (e.g. lipid hydroperoxide, LOOH), ROOH by hydrogen abstraction. |
|
1O2 |
Singlet oxygen |
Table 3: Characteristics of flavonoids structure for most effective radical-scavenging activity 71-73.
• The catechol (O-dihydroxy) group in the ring confers great scavenging ability.
• A pyrogallol (trihydroxy) group in ring B of a catechol, as in myricetin, produces even higher activity. The C2-C3 double bond of the C ring appears to increase scavenger activity because it confers stability to the phenoxy radical produced.
• The 4-oxo (keto double bond at position 4 of the C ring), especially in association with the C2-C3 double bond, increases scavenger activity by delocalizing electrons from B-ring.
• The 3-OH group on the C ring generates an extremely active scavenger; in fact, the combination of C2-C3 double bond and 4-oxo group appears to be the best combination on the top of the catechol group.
• The 5-OH and 7-OH groups may also add scavenging potential in certain cases.
In addition to their contribution to color, flavonoids also known to provide UV-B protection to plants60. UV-B is band of lowest wavelength and highest energy. It can penetrate the ozone layer in the stratosphere and hence potentially cause damage to plant life. Resistance to UV-B may take many forms, but one type of resistance could lie in flavonoid pigments, which are known to always present in green leaves. These flavonoids generally absorb in the 280-
315 nm region and thus capable of acting as UV filters. One of the undisputed functions of flavonoids and related polyphenols is their role in protecting plants against microbial invasion. This not only involves their presence in plants as constitutive agents but also their accumulation as phytoalexins in response to microbial attack61. The majority of flavonoids recognized as constitutive antifungal agents in plants are either isoflavonoids, flavans, or flavanones.
Role of Flavonoids in Animals
As these compounds have beneficial role in plants they
also known to posses variety of pharmacological activities on mammalian cells. Because of the variety of pharmacological activities on mammalian body flavonoids are more correctly referred as “Nutraceutical”.
Flavonoids As Nutraceutical
“Nutraceutical” is a term coined in 1979 by Stephen
DeFelice. It is defined “as a food or parts of food that provide medical or health benefits, including the prevention and treatment of disease.” Nutraceuticals may range from isolated nutrients, dietary supplements, and diets to genetically engineered “designer” food, herbal products, and processed products, such as cereals, soups, and beverages. The increasing interest in nutraceuticals reflects the fact that consumers hear about epidemiological studies indicating that a specific diet or component of the diet is associated with a lower risk for a certain disease. The major active nutraceutical ingredients in plants are flavonoids. As is typical for phenolic compounds, they can act as potent antioxidants and metal chelators. They also have log been recognized to possess anti-inflammatory, antiallergic, hepatoprotective, antithrombotic, antiviral, and anticarcinogenic activities, discussed below separately.
Antioxidant Activity
The best-described property of almost every group of
flavonoids is their capacity to acts as antioxidants. The flavones and catechins seem to be the most powerful flavonoids for protecting the body against reactive oxygen species (ROS). Body cells and tissues are continuously threatened by the damage caused by free radicals and ROS,
which are produces during normal oxygen metabolism or are induced by exogeneous damage62-63. Free radicals and ROS have been implicated in a large number of human diseases64-65. Quercetin, Kaempferol, Morin, Myricetin and rutin by acting as antioxidant exhibited beneficial effects, such as anti-inflammatory, antiallergic, antiviral, as well as anticancer activity. They have also been suggested to play a protective role in liver diseases, cataracts, and cardiovascular diseases. Quercetin and silybin acting as free radical scavengers were shown to exert a protective effect in liver reperfusion ischemic tissue damage66-67. The scavenging activity of flavonoids has been reported to be in the order: Myrcetin > Quercetin > Rhamnetin > Morin > Diosmetin > Naringenin > Apigenin > Catechin > 5,7-dihydroxy-3’,4’,5’-trimethoxyflavone > robinin > kaempferol > flavone68.
Antimicrobial Activity
Flavonoids and esters of phenolic acids were
investigated for their antibacterial, antifungal and antiviral activities.
Antibacterial Activity
Antibacterial activity has been displayed by a number
of flavonoids. Quercetin has been reported to completely inhibit the growth by Staphylococcus aureus. Most of the flavonones having no sugar moiety showed antimicrobial activities whereas none of the flavonols and flavonolignans tested showed inhibitory activity on the microorganisms74.
Antifungal Activity
A number of flavonoids isolated from peel of tangerine
orange, when tested for fungistatic activity towards Deuterophoma tracheiphila were found to be active; nobiletin and langeritin exhibited strong and weak activities respectively while hesperidin could stimulate fungal growth slightly. Chlorflavonin was the first chlorine-containing flavonoid-type antifungal antibiotic produced by strains of Aspergillus candidus75.
Antiviral Activity
Naturally occurring flavonoids with antiviral activity have been recognized since the 1940s, but only
recently have attempts been made to make synthetic modifications of natural compounds to improve antiviral activity. Quercetin, morin, rutin, dihydroquercetin (taxifolin), apigenin, catechin, and hesperidine have reported to possess antiviral activity against some of 11 types of viruses76. The antiviral activity appears to be associated with nonglycosidic
compounds, and hydroxylation at the 3-position is apparently a prerequisite for antiviral activity. It has been found that flavonols are more active more active than flavones against Herpes simplex virus type 1 and order of importance was galangin>kaempferol> quercetin77. Recently, a natural plant flavonoid polymer
of molecular weight 2,100 daltons was found to have antiviral activity against two strains of type 1 herpes type simplex virus and type 2 herpes simplex viruses78. Because of the world wide spread of HIV since 1980s, the investigation of the antiviral activity of flavonoids has mainly focused on HIV79. There have appeared several recent reports on anti-AIDS activity of flavonoids. Out of twenty eight flavonoids tested the flavans were generally more effective than flavones and flavonones in selective inhibition of HIV-1 and HIV-2 or similar immunodeficiency virus infection80.
Effect on Gastrointestinal system
Antiulcer Activity
Some recent have indicated that flavonoids possess
antiulcerogenic activity. Flavonoid glycosides of Ocimum basilicum (Labiatae) decreases ulcer index, and inhibited the gastric acid and pepsin secretions in aspirin induced ulcers in rats81. Quercetin, Rutin, and Kaempferol administered intraperitoneally (25-100 mg/kg) inhibited dose-dependent gastric damage produced by acidified ethanol in rats82.
Hepatoprotective Activity
The liver is subject to acute and potentially lethal injury by
several substances, including phalloidin (the toxic constituents of the mushroom Amanita phalloides), CCl4, galactosamine, ethanol, and other compounds. Flavonoids have also been found to possess hepatoprotective activity. In a study carried out to investigate the flavonoid derivatives silymarin, apigenin, quercetin, and naringenin, as putative therapeutic agents against microcrystin LR-induced hepatotoxicity, silymarin was found to be the most effective one83. The flavonoid rutin and venoruton showed regenerative and hepatoprotective effects in experimental cirrhosis84.
Anti-inflammatory Activity
Anti-inflammatory activity of flavonoids in many animal
models have been reported. Flavone/ flavonol glycosides as well as flavonoid aglycons have been reported for significant anti-inflammatory activity in animal model of both, acute and chronic inflammation when given orally or topically85-86. Hesperidin, a citrus flavonoid possesses significant anti- inflammatory and analgesic effects87. Recently apigenin, luteolin and quercetin have been reported to exhibit anti- inflammatory activity88.
A number of reports have been published which demonstrate that flavonoids can modulate arachidonic acid metabolism via inhibition of cyclo-oxygenase (COX) and lipooxygenase activity (LO). Also it has been speculated that the anti- inflammatory and anti-allergic properties of flavonoids are consequence of their inhibitory actions on arachidonic acid metabolism89. Among flavones/flavonols kaempferol, quercetin, myricetin, fisetin reported to possess LO and COX inhibitory activity 90-91.
Antidiabetic effects
Flavonoids especially Quercetin has reported to possess
antidiabetic activity. Mahmood Vessal et al reported that
quercetin, a flavonoid with antioxidant activity brings about the regeneration of pancreatic islets and proprably increases insulin release in strptozotocin- induced diabetic rats; thus exerting its beneficial antidiabetic effects92. Also in another study, Hif and Howell reported that quercetin also stimulate insulin release and enhanced Ca2+ uptake from isolated islets cell which suggest a place for flavonoids in non- insulin-dependent diabetes93-94.
Effect on Cardiovascular system
Vasorelaxant agent
The consumption of flavonoids may prevent the
endothelial dysfunction by enhancing the vasorelaxant process leading to reduction of arterial pressure95-96. Endothelial dysfunction represents critical event in the development of cardiovascular diseases and the major complication of atherosclerosis and arterial thrombus formation97.
The consumption of flavonoids can be able to prevent a number of cardiovascular diseases including hypertension and atherosclerosis98-99. Really many experimental studies have shown that these polyphenolic compounds may reduce the arterial pressure in rats and enhance the vasorelaxant process. The endothelium dependent relaxation induced by
scavenge free radicals, thereby maintaining proper concentration of endothelial prostacyclin and nitric oxide107. One study showed that flavonoids are powerful antithrombotic agents in vitro and in vivo because of their inhibition of the activity of cyclooxegenase and lipoxigenase pathways108.
Cardioprotective effects
Recent interest in flavonoids has been stimulated by the
potential
health benefits arising from the antioxidant activity of these ployphenolic compounds.these are the result of their
high propensity to transfer electrons, to chelate ferrous ions, and to scavenge reactive oxygen species109. Because of these
properties, flavonoids have been considered as potential
protectors against chronic cardiotoxicity caused by the
cytostatic drug doxorubicin. Doxorubicin
is very effective antitumor
agents, but its clinical use is limited by the occurrence of a cumulative dose related cardiotoxicity,
resulting
in, for example, congestive heart failure (negative inotropic effect). In the recent report the cardiotoxicity of
doxorubicin on the mouse left atrium has been inhibited by
flavonoids, 7-monohydroxyethylrutoside
and 7’,3’,4’-
trihydroxyethylrutoside (34)110-112.
![]()
![]()
flavonoids has been well documented. Also
investigators have demonstrated
that Anthocyanin
delphinidin exerts a significant endothelium
dependent vasorelaxation100-101.
Antiatherosclerotic effects
Oxidative
modification
of
low-density lipoproteins
(LDL) by free radicals is an early event in the pathogenesis of atherosclerosis. The rapid uptake of oxidatively modified LDL via a scavenger receptor leads to the formation of foam cells. Flavonoids may directly scavenge some radical species by acting as a chain braking antioxidant102. The ability of quercetin, and the quercetin glycosides, to protect LDL against oxidative modification has shown a significant protective effect103. Furthermore, a Japanese study reported an inverse correlation between flavonoid intake and total plasma cholesterol concentrations104.
Antithrombogenic effects
Platelet aggregation plays a pivotal role in the
physiology of thrombotic disesases. Activated platelets adhering to vascular endothelium generate lipid peroxides and oxygen free radicals, which inhibit the endothelial formation of prostacyclin and nitrous oxide. It was shown in 1960s that tea pigment can reduce blood coagulability, increase fibrinolysis, and prevent platlet adhesion and aggregation105. Selected flavonoids, such quercetin, kaempferol, and myricetin were shown to be effective inhibitors of platelet aggregation in dogs and monkeys106. Flavonols are particularly antithrombotic because they directly
7-m on o hy d rox y eh ty lruto side (3 4)
Figure 14. Example for the chemical structure of a 7’,3’,4’- trihydroxyethylrutoside (34).
Antineoplastic Activity
A sufficient number of flavonoids have exhibited antineoplastic activity. Several recent reviews have highlighted this activity of flavonoids. Detailed studies113-115 have revealed that quercetin exerted a dose dependent inhibition of growth and colony formation. The flavonoids
kaempferol, catechin, toxifolin and fisetin also suppressed cell growth116-117. On screening antileukaemic efficacy of 28 naturally occurring and synthetic flavonoids on human promyelocytic leukaemic HL-60 cells, genistein, an isoflavone was found to have strong effect118-119.
Effect on Central Nervous System
Synthetic flavonoids like 6-bromoflavone and 6-bromo-3’-
nitroflavones were shown to displace [3H] flumazenil binding to membranes from rat cerebellum but not from spinal cord, indicating selectivity for the BZ-Omega receptor subtype, but latter was very potent than 6-bromoflavone. Results from two conflict tests in rats showed that these synthetic flavonoids possess anxiolytic like properties similar or superior to that of diazepam120.
Figure 15. The Links that indicating effects of flavonoids on different diseases.
TOXICITY OF FLAVONOIDS
Flavonoids are ubiquitous in plants foods and drinks
and therefore a significant quantity is consumed in our daily diet. The toxicity of flavonoids is very low in animals. For rats, the LD50 is 2-10 gm per animal for most flavonoids. Similar doses humans are quite unrealistic. As a precaution, doses less than 1mg per adult per day have been recommended for humans121. Dunnick and Hailey reported that high doses of quercetin over several years might result in the formation of tumors in mice122. However, in other long-term studies, no carcinogenicity was found123. Moreover, as describe earlier quercetin reported to be anti-mutagenic in vivo.
CONCLUSION AND PERSPECTIVE: Flavonoids comprise a vast array of biologically active compounds ubiquitous in plants, many of which have been used in traditional eastern medicine for thousands of years. Also they constitute an unavoidable component of the diet. In the present review we have evoked detail structural aspects, pathways responsible for biosynthetic and chemical synthetic methodologies and biological properties of flavonoids. A biosynthetic pathway explores the flavonoid metabolism processes. Studies of flavonoid metabolism are increasingly intertwined with efforts to understand a wide array of other primary and secondary metabolic systems. It seems likely that flavonoid metabolism will continue to serve as an important and tractable experimental model for efforts to understand cellular metabolism for some time to come. Also this review focuses a light on the various chemical synthetic pathways of flavonoids. The synthesis of bioflavonoids represents a challenge for chemists, in terms of multi-step synthesis and regioselective modification. Among all the methods reported in this review chalcones and diketones were frequently registered as intermediates of flavonoid synthesis, which show that the aldolisation is the key step in flavonoid synthesis. So we have given direct focus on aldolisation with minimum protection to obtain polyhydroxylated flavonoids. Furthermore,
flavonoids constitute a best base chemical structure for new hemisynthetic drugs. Chemical and structural similarities of flavonoids with numerous biomolecules as well as their crucial role in plant-insect and plant-bacterial interactions make them attractive class of phytoconstituents for biological activity. Their wide spread occurrence, broad spectrum diversity and natural origin make them appropriate chemical scaffolds for novel therapeutic agents. Of many actions of flavonoids, antioxidant and antiproliferative effects stand out. Given that certain substituents are known to be required or increase their actions, the therapeutic potential of selected flavonoids is fairly obvious.these natural compounds have several great advantages over other therapeutic agents since:
i) Our diet is rich in these phenolics and they are daily consumed.
ii) They rarely have any side effects. iii) They have relatively long half-life.
iv) They can easily absorbed in intestine after ingestion.
The study of flavonoids is complex because of heterogeneity of different molecular structures and the scarcity of data on bioavailability. There is need to improve analytic techniques to allow collection of more data on absorption and excretion. Data on the long term consequences of chronic flavonoid ingestion are especially scare. Finally, we would think that natural, hemisynthetic and synthetic flavonoids alone or in combination with other preventive and/or therapeutic strategies will become an effective future drugs against most common degenerative diseases such as cancer, diabetes, cardiovascular complications.
REFERENCES:
1. De Groot H and Raven U. Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam Clin Pharma Col. 1998; 12:249-255.
2. Robak J and Gryglewski RJ. Bioactivity of flavonoids. Pol J Pharmacol. 1996; 48:555-564.
3. Ranaud S and de Lorgeril M. Wine, alcohol, platelets, and the french paradox for coronary heart disease. Lancet. 1992; 339(8808):1523-1526.
4. Harborne JB. The flavonoids- Advances in Research Since 1980. Chapman and Hall, London. 1988. 1st ed.
5. Middleton E. The flavonoids. Trends Pharmacol Sci. 1984;5:335-338.
6. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol. 1983;32(7):1141-1148.
7. Harborne JB. Nature, distribution and function of plant flavonoids. In Cody V, Middleton Elliott Jr, Harborne JB.Plant flavonoids in biology and medicine: biochemical, pharmacological and structure activity relationship. Alan R Liss, Inc, New York, USA.1986; pp. 15-24.
8. Barron D and Ibrahim RK. Isoprenylated flavonoids- a survey. Phytochem. 1996; 43(5):921-982.
9. Harborne JB and Baxter, H. The handbook of natural flavonoids. Vol.1-2. John Wiley and son, New York. 1999.
10. Wong E. Chemistry and biochemistry of plant pigments. Academic press, London. 1976. 2nd ed.
11. Das DK. Naturally occurring flavonoids: structure, chemistry and high performance liquid chromatographic methods for separation and characterization. Methods Enzymol. 1994; 234:410-420.
12. Heller W and Forkmann G. Biosynthesis in the flavonoids. In Harborne JB. Advances in research since 1986.Chapmann and Hall Ltd., London.1993; pp. 499-535.
13. Jensen RA. The shikimate/arogenate pathway: Link between carbohydrate metabolism and secondary metabolism. Physiol Plant. 1986; 66:164.
14. Dewick PM. The biosynthesis of shikimate metabolites. Nat Prod Rep. 1986; 3:565-588.
15. Dewick PM. The biosynthesis of shikimate metabolites. Nat Prod Rep. 1988; 5:73-97.
16. Ayabe S, Udagawa A and Furuya T. NAD(P)H- dependent 6’-deoxychalcone synthase activity in Glycyrrhiza echinata cells induced by yeast extract. Arch Biochem Biophys. 1988; 261(2):458-462.
17. Wagner H and Farkas L. Synthesis of flavonoids. In Harborne JB, Mabry TJ, Mabry H. The flavonoids Part I. Academic press, New York. 1975; pp. 127-213.
18. Ayabe S, Udagawa A and Furuya T. Stimulation of chalcone synthase activity by yeast extract in cultured Glycyrrhiza echinata cells and 5-deoxy flavanone formation by isolated protoplast. Plant Cell Rep. 1988; 7:35-38.
19. Hakamatsuka T et al. Deoxychalcone synthase from cell suspension cultures of Pueraria lobatia. Chem Pharm Bull. 1988; 36(10):4225-4228.
20. Britsch L. Purification and characterization of flavone synthase I, a 2-oxoglutarate dependent desaturase. Arch Biochem Biophys. 1990; 282(1):152-160.
21. Kochs G and Grisebach H. Induction and characterization of NADPH dependent flavone synthase from cell cultures of soybean. Naturforch. 1987; 42 c:343-348.
22. Fischer D et al. Purification and characterization of (+) Dihydroflavonol, 3-hydroxyflavonol 4-reductase from flowers of Dalhia variabilis. Arch Biochem Biophys. 1988; 264(1):40-47.
23. Britsch L and Grisebach H. Purification and characterization of (2S)-flavanone 3-hydroxylase from Petunia hybrida. Eur J Biochem. 1986; 156:569-577.
24. Britsch L. Purification of flavanone 3 beta hydroxylase from Petunia hybrida: antibody preparation and characterization of a chemigenetically defined mutant. Arch Biochem Biophys. 1990; 276(2):348-354.
25. Stich K and Forkmann G. Biosynthesis of 3-deoxyanthocyanins with flower extracts from Sinningia cardinalis. Phytochem. 1988; 27:785-789.
26. Britsch L, Ruhnau B and Forkmann G. Molecular cloning sequence analysis and in vitro expression of flavanone 3 beta-hydroxylase from Petunia hybrida. J Biol Chem. 1992; 267(8):5380-5387.
27. Beerhues L et al. Flavanone 3-hydroxylase and dihydroflavonol oxygenase activities in anthers of Tulipa. The significance of the Tapetum fraction in the flavonoid mechanism. In the flavonoid mechanism. Plant Physiol. 1989; 133:743-746.
28. Stafford HA and Lester HH. Enzymatic and non enzymatic reduction of (+)-Dihydroquercetin to its 3, 4 diol. Plant Physiol. 1982; 70:695-698.
29. Stafford HA. Proanthocyanidins and the lignin connections. Phytochem. 1988; 27:1-6.
30. Stafford HA and Lester HH. Flavan-3-ol biosynthesis. Plant Physiol 1984; 76:184-186.
31. Brenda Winkel-Shirley. Flavonoid Biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology. Plant Physiol. 2001; 126:485-493.
32. Harborne JB and Christine AW. Advances in flavonoid research since 1992. Phytochem. 2000; 55:481-504.
33. Harborne JB, Mabry TJ and Mabry M. The flavonoids. Chapmann and Hall, London. 1975. 1st ed.
34. Allan J and Robinson R. An accessible derivatives of chromonol. J Chem Soc. 1924; 125:2192-2195.
35. Baker W. Molecular rearrangement of some O-acyloxyacetophenone and the mechanism of the production of 3-acylchromones. J Chem Soc. 1933; 55:1381-1389.
36. Mahal HS and Venkataraman K. Synthetical experiments in the chromone group. Part XIV: The action of sodamide on 1- Acyloxy-2-acetophthanones. J Chem Soc. 1934; 56:1767-1769.
37. Muller E et al. Synthesis of spin labeled chromones. Synthesis. 2000; 10:1415-1420.
38. Bois F et al. A one step synthesis of 5-hydroxyflavones. Synlett. 1999; 9:1480-1482.
39. Hauteville M et al. Synthesis of novel C-methylflavones. Liebigs Ann. 1996; 1217-1222.
40. Krohn K, Roemer E and Top M. Total synthesis of aklanonic acid and derivatives by Baker-Venkataraman rearrangement. Liebigs Ann. 1996; 271-277.
41. Geissman TA and Clinton O. Flavanones and related compounds I. The preparation of polyhroxychalcones and flavanones. J Amer Chem Soc. 1946; 68(4), 697-700.
42. Furlong JJP and Nudelman NS. Mechanism of cyclisation of 2’-hydroxychalcone to flavanones. J Chem Soc Perkin Trans II. 1985; 633-639.
43. Sangwan NK, Varma BS and Dhindsa KS. Silica gel as potential catalyst for isomerization of substituted 2’-hydroxychalconeto the corresponding flavanones. Chem Ind. 1984; 6:271-272.
44. Matsushima R and Kageyama H. Photochemical cyclisation of 2’-hydroxychalcone. J Chem Soc Perkin Trans II. 1985; 743-748.
45. Maruyama K et al. Conversion of 2’-hyroxychalcones to flavanones catalysed by cobalt Schiff base complex. Tetrahedron Lett. 1989; 30(31):4145-4148.
46. Kashara A, Izumi T and Oshima M. A new method for preparing flavones. Bull Chem Soc Jpn. 1974; 47(10):2526-2528.
47. Maki Y et al. Photo-oxidative cyclisation of 2’- hydroxychalcones leading to flavones induced by heterocycle n-oxides: high efficiency of pybimido[54-8]pteridine n-oxide for the photochemical dehydrogenation. Tetrahedron. 1988; 44(11):3187-3194.
48. Harris KM and Carney RL. Synthesis of 3,5,7-triketo acids and esters and their cyclisation to resorcinol and phloroglucinol derivatives. Model of biosynthesis of phenolic compounds. J Amer Chem Soc. 1967; 89(25):6734-6741.
49. Sanicanin Z and Tabakovic I. Electrochemical transformation of 2’-hydroxychalcones into flavonoids. Tetrahedron Lett. 1986; 27(3):407-408.
50. Ali SM, Iqubal J and Ilyas M. J Chem Research. 1984; 256.
51. Emilwicz T and von Kostanecki S. Syntheses des 3- oxyflavone. Chem Ber. 1898; 31:696-705.
52. Algar J and Flynn JP. A new method for the synthesis of flavonols. Proc R Ir Acad sect B. 1934; 42:1-4.
53. Oyamada T. A new method for the synthesis of flavonol. J Chem Soc Jpn. 1934; 55:1256-1261.
54. Labeau J, Neviere R and Cotelle N. Beneficial effects of different flavonoids on functional recovery after ischemia and reperfusion in isolated rat heart. Biorg Med Chem Lett. 2001; 11:23-37.
55. Hercouet A, Le Corre M and Le Floch Y. A simple synthesis of chromones. Synthesis. 1982; 597-599.
56. Le Floch Y and Le Fleuve M. Syntheses de trihydroxyphenacyclidene triphenylphosphanes. Une nouvelle voie d’accesaux dihydroxyflavones. Tetrahedron Lett. 1986; 27:5503-5504.
57. Subramanian RS and Balasubramanian KK. Mecury (II) trifluoroacetate-mediated transformation of 3-bromo-1- phenylprop-2-ynyl arly ethers; a novel synthesis of flavanones. J Chem Soc Chem Commun. 1990; 1469-1470.
58. Brack et al. Photochemical formation of 4’-N,N- dimethylamino-3-hydroxyflavone in hydrocarbon solutions of 4-N,N-dimethylamino-2’-hydroxychalcone. Tetrahedron Lett. 1999; 40:3995-3998.
59. Kondo T et al. Commelinin, a highly associated metalloanthocyanin present in the blue flower petals of Commelina communis. Nature. 1992; 358:515-517.
60. Kootstra A. Protection from UV-B induced DNA damage by flavonoids. Plant Mol Biol. 1994; 26(2):771- 774.
61. Grayer RJ, Harborne JB. A survey of antifungal compounds from higher plants. Phytochem. 1994;37:19-42.
62. De Groot H. Reactive oxygen species in tissue injury. Hepatogastroenterol. 1994; 41:328-332.63.
63. Grace PA. Ischaemia-reperfusion injury. Br J Surg. 1994; 81:637-647.
64. Wegener T and Fintelmann V. Flavonoids and bioactivity. Wein Med Wochem Schr. 1999; 149:241-247.
65. Ares JJ and Outt PE. Gastroprotective agents for the prevention of NSAID induced gastropathy. Curr Pharm Des. 1998; 4:7-36.
66. Hillwell B. Free radicals, antioxidants and human disease: Curiosity, cause or constipation? Lancet. 1994; 344:721-724.
67. Fraga CG et al. Flavonoids as antioxidants evaluated by in vitro and in situ liver chemiluminescence. Biochem Med Metabol Biol. 1987; 36:717-720.
68. Ratty AK. Effects of flavonoids on nonenzymatic lipid peroxidation: structure activity relationship. Biochem Med Metabol Biol. 1988; 39;67-79.
69. Bors W et al. Flavonoids as antioxidant: Determination of radical scavenging efficiencies. Methods Ezymol. 1990; 186:343-355.
70. Cotelle N et al. Antioxidant activity of hydroxy flavonoids. Free Radic Biol Med. 1996; 20:35-43.
71. Rice-Evans CA, Nicholas JM and Paganga G. Structure- antioxidant activity relationships of flavonoids and phenolic acid. Free Radic Biol Med. 1996; 20(7)-933-956.
72. Amic D et al. Structure radical scavenging activity relationships of flavonoids. Croat Chem Act. 2003; 76:55-61.
73. Farkas O, Jakus J and Heberger K. Quantitative structure- antioxidant activity relationship of flavonoid compounds. Molecules. 2004; 9:1079-1088.
74. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol. 1983;32(7):1141-1148.
75. Tencate JW et al. Biological activity of a semisynthetic flavonoid O-(β-hydroxyethyl) rutosine: Light scattering and metabolic studies of human red cells and platelets. Clin Chem. 1973; 19:31-35.
76. Selway JWT. Antiviral activity of flavones and flavans. In Cody V, Middleton E, Harborne JB. Plant flavonoids in biology and medicine: Biochemical, pharmacological and structure activity relationships. Alan R Liss, Inc, New York. 1986. pp. 521-536.
77. Thomas PRS, Nash GB and Dormandly JA. White cells accumulation in dependent legs of patients with venous hypertension: A possible mechanism for trophic changes in the skin. Br Med J. 1988; 296:1673-1695.
78. Loewenstein WR. Junctional Intercellular communication and the control of growth. Biochem Biophys Acta. 1979; 560:1-65.
79. Ng TB et al. Anti-human immunodeficiency virus (anti-HIV) natural products with special emphasis on HIV transcriptase inhibitors. Life Sci. 1997; 61:933-949.
80. Gerdin B and Srensso E. Inhibitory effect of flavonoids on increased microvascular permeability induced by various agents in rat skin. Int J Micro Cir Clin Exp. 1983; 2:39-46.
81. Alarcon DL et al. Antiulcerogenic activity of flavonoids and gastric protection. Ethnopharmacol. 1994; 42:161-170.
82. Izzo AA et al. Effect of quercetin on gastrointestinal tract. Phyto Ther Res. 1994; 8:179-185.
83. Carlo GD et al. Inhibition of intestinal motility and secretion by flavonoids in mice and rats; structure activity relationships. J Pharm Pharmcol. 1993; 45:1045-1059.
84. Lorenz W et al. Action of several flavonoids on enzyme of histidine metabolism in vivo. In Cz Maslinski. Histamine. Hutchinson and Ross, Pennsylvania. 1994. pp. 265-269.
85. Lee SJ et al. Anti-inflammatory activity of naturally occurring flavone and flavonol glycosides. Arch Pharm Res. 1993; 16(1):25-28.
86. Hang T et al. Evaluation of anti-inflammatory effects of baicalein on dextran sulfate sodium-induced colitis in mice. Planta Med. 2002; 68(2):268-271.
87. Shahid F, Yang Z and Saleemi ZO. Natural flavonoids as stabilizers. J Food Lipids. 1998; 1:69-75.
88. Farmica JV and Regelson W. Review of the biology of quercetin and related bioflavonoids. Fd Chem Toxic. 1995;33(12):1061-1080.
89. Ferrandiz ML and Alcaraz MJ. Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids. Agent and Actions. 1991; 32(3/4):283-288.
90. Kim HP et al. Effects of naturally occurring flavonoids and bioflavonoids on epidermal cycloxygenase and lipoxygenase from guinea pigs. Prostag Leukot Essent Fatty acids. 1998; 58:17-24.
91. Jachak SM. Natural products: Potential source of COX inhibitors. CRIPS. 2001; 2(1):12-15.
92. Vessal M, Hemmati M and Vasei M. Antidiabetic effects of quercetin in streptozocin induced diabetic rats. Comp Biochem Physiol C. 2003; 135:357-364.
93. Hif CS and Howell SL. Effects of epicatechin on rat islets of langerhans. Diabetes. 1984; 33:291-296.
94. Hif CS and Howell SL. Effects of flavonoids on insulin secretion and 45Ca+2 handling in rat islets of langerhans. J Endocrinol. 1985; 107:1-8.
95. Iijima K and Aviram M. Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr Opin Lipidol. 2001; 12:41-48.
96. Bernatova I et al. Wine polyphenols improve cardiovascular remodeling and vascular function in NO- deficient hypertension. Am J Physiol Heart Cir Physiol. 2002; 282:942-948.
97. Jayakody TL et al. Cholesterol feeding impairs endothelium-dependent relaxation of rabbit aorta. Can J Physiol Pharmacol. 1985; 63:1206-1209.
98. Hertag MG et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the zutphen elderly study. Lancet. 1993; 342:1007-1011.
99. Hertog MG et al. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer. 1993; 20:21-29.
100. Andriambeloson E et al. Nitric oxide production and endothelium dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol. 1997; 120:1053-1058.
101. Burns J et al. Relationship among antioxidant activity, vasidilation capacity and phenolic content of red wines. J Agric Food Chem. 2000; 48:220-230.
102. De-whallely C et al. Flavonoids inhibit the oxidative modification of low density lipoprotein by macrophages. Biochem Pharmacol. 1990; 39:1743-1750.
103. Fuhrman B, Lavy A and Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoproteins to lipid peroxidation. Am Soc Nutr. 1995; 61:549-554.
104. Arai Y et al. Dietary intake of flavonols, flavones and isoflavones by Japanesee women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr. 2000; 130:2243-2250.
105. Lou FQ et al. A study on tea pigment in prevention of antherosclerosis. Chin Med J (Engl). 1989; 102:579- 583.
106. Osman HE et al. Grape juice but not orange or grapefruit juice inhibits plate activity in dogs and monkey’s. J Nutr. 1998; 128:2307-2312.
107. Gryglewski RJ et al. On the mechanism of anti thrombotic action of flavonoids. Biochem Pharmacol. 1987; 36:317-322.
108. Alcaraz MJ and Ferrandiz ML. Modification of arachidonic metabolism by flavonoids. J Ethnopharmacol. 1987; 21:209- 229.
109. Kandaswami C and Middleton E. Free radical scavenging and antioxidant activity of plant flavonoids. In Armstrong D. Free radicals in diagnostic medicine. Plenum Press, New York. 1994; 2nd ed: pp. 351-376.
110. Lackeman GM et al. Chronotropic effect of quercetin on guinea pig right atrium. J Planta Med. 1986; 52:433-439.
111. Huesken BCP et al. Flavonoids as cardioprotective agents. Cancer Chemotheapy Pharmacol. 1995; 37:55-62.
112. Bast A et al. Protectors against doxorubicin-induced cardiotoxicity: Flavonoids. Cell Biol Toxicol. 2007; 23:39-47.
113. Kontruck SJ et al. Antiulcer and gastroprotective effects of solon, a synthetic flavonoid derivative of sophorandin. Role of endogenous prostaglandins. Bur J Pharmac. 1986; 125:185-192.
114. Izzo AA et al. Antiulcer effects of flavonoids. Role of endogenous PAF. Phytotherapy Res. 1991; 8:179-81.
115. Murakami S, Muramatsu M and Otomo S. Gastric H+/K+ ATPase inhibition by catechins. J Pharm Pharmacol. 1992; 44:926-928.
116. Kim HK, Namgoong SY and Kim HP. Biological actions of flavonoids-I. Arch Pharmacol Res. 1993; 16:18-27.
117. Gill B, et al. The flavonoids. Life Sci. 1994; 54:333-339.
118. Hirano T, Gotoh M and Oak K. Natural flavonoids and lignans are plant cytostatic agents against Human Leukemic HL-60 cells. Life Sci. 1994; 55:1061-1069.
119. Wei H et al. Inhibitory effect of Apigenin, a plant flavonoids on epidermal ornithine decarboxylase skin tumor promotion in mice. Cancer Res. 1990; 50: 499-502.
120. Griebel G et al. Pharmacological studies on synthetic flavonoids: Comparison with diazepam. Neuropharmacol.1999; 38:965-977.
121. Starvic B. Mutagenic food flavonoids. Fed Proc. 1984;43:2344.
122. Dunnick JK and Hailey JR. Toxicity and carcinogenicity studies of quercetin, a natural component of food. Fundam Appl Toxicol. 1992; 19:423-431.
123. Plakas SM, Lee TC and Wolke RE. Absence of overt toxicity from feeding the flavonol, quercetin t rainbow trout (Calmo gairdneri). Food Chem Toxicol. 1985; 23:1077-1080.
Received on 26.05.2008 Modified on 10.07.2008
Accepted on 28.08.2008 © RJPT All right reserved
Research J. Pharm. and Tech. 1(3): July-Sept. 2008; Page 132-143